Effects of Behcet's disease on hearing thresholds and transient evoked otoacoustic emissions

Journal of Otolaryngology

Volumn 36, Issue 4, 2007, Pages 220-226

  Muluk, Nuray Bayar ^a,b   Birol, Ahu ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b Birlik Mahallesi   (Turkey)

Author keywords

Beh et disease; High frequency audiometry; Transient evoked otoacoustic emissions

Indexed keywords

ADULT; AGE; ARTICLE; AUDIOMETRY; AUDITORY THRESHOLD; BEHCET DISEASE; CLINICAL ARTICLE; COCHLEA; CONTROLLED STUDY; DISEASE DURATION; EVOKED OTOACOUSTIC EMISSION; FEMALE; HEARING LOSS; HIGH FREQUENCY AUDIOMETRY; HUMAN; INNER EAR DISEASE; MALE; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY; SEX DIFFERENCE; CASE CONTROL STUDY; DISEASE COURSE; EVOKED RESPONSE AUDIOMETRY; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADULT; AUDIOMETRY, EVOKED RESPONSE; BEHCET SYNDROME; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; LINEAR MODELS; MALE; PROSPECTIVE STUDIES;

EID: 34948813076     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7010.2007.0043     Document Type: Article

References (27)

1. Behçet H. Uber rezidivierende Aphthose, durch ein Virus verursachte geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937;105:1152-7.
2. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
3. International Study Group for Behçet's Disease. Evaluation of diagnostic ('classification') criteria in Behçet's disease - towards internationally agreed criteria. Br J Rheumatol 1992;31:299-308.
4. Yazici H, Urdakul S, Hamuryudan V. Behçet's syndrome. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Oxford textbook of rheumatology, 2nd ed. Oxford: Oxford Medical Publications; 1998. p. 1394-403.
5. Chajek T, Fainaru M. Behçet's disease. Report of 41 cases and review of the literature. Medicine 1975;4:179-84.
6. Joynt RJ, editor. Clinical neurology. Philadelphia: JB Lippincott; 1992.
7. Farah S, Al-Shubaili A, Montaser A, et al. Behçet's syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatry 1998;64:382-4.
8. Erdinç AK, Harputluoglu U, Oghan F, et al. Behçet's disease and hearing loss. Auris Nasus Larynx 2004;31:29-33.
9. Alajouanine T, Castaigne P, Lhermitte F, et al. La meningoencephalite de la maladie de Behçet. Presse Med 1961;69:2579-82.
10. Gemignani G, Berrettini S, Bruschini P, et al. Hearing and vestibular disturbances in Behçet's syndrome. Ann Otol Rhinol Laryngol 1991;100:459-63.
11. Belkahia A, Ben H'mida M, Hamza M. Les atteintes auditives et vestibulaires dans la maladie de Behçet. Ann Otolaryngol 1982;99: 469-76.
12. Andreoli C, Savastano M. Audiologic pathology in Behçet's syndrome. Ann J Otol 1989;10:466-7.
13. Hilger AW, Durness DN, Wilson JP. The possible relationship between transient evoked otoacoustic emissions and organ of Corti irregularities in the guinea pig. Hear Res 1995;84:1-11.
14. Stavroulaki P, Apostolopoulas N, Dinopoulou D, et al. Otoacoustic emissions - an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 1999;50: 177-84.
15. Glattke TI, Robinette MS. Transient evoked otoacoustic emissions. In: Robinette MS, Glattke TJ, editors. Otoacoustic emissions: clinical applications. New York: Thieme; 1997. p. 63-82.
16. Khvoles R, Freeman S, Sohmer H. Transient evoked otoacoustic emissions in laboratory animals. Audiology 1999;38:121-6.
17. Green DS. Pure tone airconduction testing. In: Katz J, editor. Handbook of clinical audiology, 2nd ed. Baltimore: Waverly Press; 1983. p. 98-108.
18. 52nd World Medical Association General Assembly. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects JAMA 2000;284:3043-9.
19. Evereklioglu C, Cokkeser Y, Doganay S, et al. Audio-vestibular evaluation in patients with Behçet's syndrome. J Laryngol Otol 2001;115:704-8.
20. Siva A, Altintas A. Neuro-Behçet syndrome. In: Said G, editor. Treatment of neurological disorders with intravenous immunoglobulins. London: Martin Dunitz; 2000. p. 115-26.
21. Pollak L, Luxon LM, Haskard DO. Labyrinthine involvement in Behçet's syndrome. J Laryngol Otol 2001;115:522-9.
22. Soylu L, Aydogan B, Soylu M, et al. Hearing loss in Behçet's disease. Ann Otol Rhinol Laryngol 1995;104:864-7.
23. Brama I, Fainaru M. Inner ear involvement in Behçet's disease. Arch Otolaryngol 1980;106:215-7.
24. Baloh RW, Halmagyi GM. Disorders of the vestibular system. New York: Oxford University Press; 1996.
25. Hagiwara N, Harashima S, Tukamoto H, et al. A case of Behçet's disease with chronic and repeated sudden hearing loss: successful treatment with intravenous cyclophosphamide pulse therapy. Ryumachi 2001;41:858-63.
26. Elidan J, Levi H, Cohen E, et al. Effect of cyclosporine A on the hearing loss in Behçet's disease. Ann Otol Rhinol Laryngol 1991;100:464-8.
27. Tsunoda I, Kanno H, Watanabe M, et al. Acute simultaneous bilateral vestibulocochlear impairment in neuro-Behçet's disease: a case report. Auris Nasus Larynx 1994;21:243-7.